Trivalent arsenic species induce changes in expression and levels of proinflammatory cytokines in intestinal epithelial cells

Toxicology Letters

Volumn 224, Issue 1, 2014, Pages 40-46

  Calatayud, M ^a   Gimeno Alcaniz J V ^a   Velez D ^a   Devesa, V ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Arsenic; Caco 2; Cytokines; Inflammation; Intestinal epithelium

Indexed keywords

ARSENIC; CHLORMETHINE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; LIMIT OF QUANTITATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SALMONELLA ENTERICA;

ARSENIC; CACO-2; CYTOKINES; INFLAMMATION; INTESTINAL EPITHELIUM;

ARSENIC; CACO-2 CELLS; CACODYLIC ACID; CYTOKINES; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; INTESTINAL MUCOSA; ORGANOMETALLIC COMPOUNDS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887536598     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.09.016     Document Type: Article

References (51)

1. Ahmed S., Khoda S.M., Rekha R.S., Gardner R.M., Ameer S.S., Moore S., Ekström E.-C., Vahter M., Raqib R. Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ. Health Perspect. 2011, 119:258-264.
2. Alava P., Tack F., Du Laing G., Van de Wiele T. HPLC-ICP-MS method development to monitor arsenic speciation changes by human gut microbiota. Biomed. Chromatogr. 2012, 26:524-533.
3. Amin P.B., Diebel L.N., Liberati D.M. The synergistic effect of ethanol and shock insults on Caco(2) cytokine production and apoptosis. Shock 2008, 29:631-635.
4. Banerjee M., Saxena M. Interleukin-1 (IL1) family of cytokines: role in type 2 diabetes. Clin. Chim. Acta 2012, 413:1163-1170.
5. Borgoño J.M., Vicent P., Venturino H., Infante A. Arsenic in drinking-water of city of Antofagasta - epidemiological and clinical-study before and after installation of a treatment-plant. Environ. Health Perspect. 1977, 19:103-105.
6. Bourdonnay E., Morzadec C., Fardel O., Vernhet L. Redox-sensitive regulation of gene expression in human primary macrophages exposed to inorganic arsenic. J. Cell Biochem. 2009, 107:537-547.
7. Bourdonnay E., Morzadec C., Sparfel L., Galibert M.D., Jouneau S., Martin-Chouly C., Fardel O., Vemhet L. Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol. Immunol. 2009, 46:649-656.
8. Brozek W., Bises G., Fabjani G., Cross H.S., Peterlik M. Clone-specific expression, transcriptional regulation, and action of interleukin-6 in human colon carcinoma cells. BMC Cancer 2008, 8:13.
9. Bruewer M., Luegering A., Kucharzik T., Parkos C.A., Madara J.L., Hopkins A.M., Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J. Immunol. 2003, 171:6164-6172.
10. Calatayud M., Devesa V., Vélez D. Differential toxicity and gene expression in Caco-2 cells exposed to arsenic species. Toxicol. Lett. 2013, 218:70-80.
11. Calatayud M., Vélez D., Devesa V. Metabolism of inorganic arsenic in intestinal epithelial cell lines. Chem. Res. Toxicol. 2012, 25:2402-2411.
12. Daig R., Andus T., Aschenbrenner E., Falk W., Schölmerich J., Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996, 38:216-222.
13. EFSA Panel on Contaminants in the Food Chain (CONTAM): scientific opinion on arsenic in food. EFSA J. 2009, 7(10):1351.
14. Germolec D.R., Spalding J., Yu H.S., Chen G.S., Simeonova P.P., Humble M.C., Bruccoleri A., Boorman G.A., Foley J.F., Yoshida T., Luster M.I. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am. J. Pathol. 1998, 153:1775-1785.
15. Haque R., Mazumder D.N.G., Samanta S., Ghosh N., Kalman D., Smith M.M., Mitra S., Santra A., Lahiri S., Das S., De B.K., Smith A.H. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology 2003, 14:174-182.
16. Hernández-Castro B., Doníz-Padilla L.M., Salgado-Bustamante M., Rocha D., Ortiz-Pérez M.D., Jiménez-Capdeville M.E., Portales-Pérez D.P., Quintanar-Stephano A., González-Amaro R. Effect of arsenic on regulatory T cells. J. Clin. Immunol. 2009, 29:461-469.
17. Hershko D.D., Robb B.W., Hungness E.S., Luo G., Guo X., Hasselgren P.-O. Arsenite inhibits interleukin-6 production in human intestinal epithelial cells by downregulating nuclear factor-κB activity. Clin. Sci. 2002, 103:381-390.
18. Heywood R., Sortwell R.J. Arsenic intoxication in the Rhesus-Monkey. Toxicol. Lett. 1979, 3:137-144.
19. Huang Y.-K., Tseng C.-H., Huang Y.-L., Yang M.-H., Chen C.-J., Hsueh Y.-M. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol. Appl. Pharmacol. 2007, 218:135-142.
20. Hyun J.S., Satsu H., Shimizu M. Cadmium induces interleukin-8 production via NF-kappaB activation in the human intestinal epithelial cell, Caco-2. Cytokine 2007, 37:26-34.
21. IARC IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs 2004, vol. 84:39. International Agency for Cancer Research.
22. Jung H.C., Eckmann L., Yang S.K., Panja A., Fierer J., Morzycka-Wroblewska E., Kagnoff M.F. A distinct array of proinflammatory cytokines is expressed in human colon epithelial-cells in response to bacterial invasion. J. Clin. Invest. 1995, 95:55-65.
23. Kozul C.D., Hampton T.H., Davey J.C., Gosse J.A., Nomikos A.P., Eisenhauer P.L., Weiss D.J., Thorpe J.E., Ihnat M.A., Hamilton J.W. Chronic exposure to arsenic in the drinking water alters the expression of immune response genes in mouse lung. Environ. Health Perspect. 2009, 117:1108-1115.
24. Kumagai Y., Sumi D. Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Ann. Rev. Pharmacol. 2007, 47:243-262.
25. Liu J., Liu Y., Goyer R.A., Achanzar W., Waalkes M.P. Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. Toxicol. Sci. 2000, 55:460-467.
26. Lynes M.A., Pietrosimone K., Marusov G., Donaldson D.V., Melchiorre C., Yin X., Laurence D.A., McCabe M.J. Metal influences on immune function. Metal and Molecular Biology of Metals 2010, 379-414. CRC Press, Taylor and Francis Group, New York. R.K. Zalups, J. Koropatnick (Eds.).
27. Madara J.L., Stafford J. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 1989, 83:724-727.
28. Majumdar K.K., Mazumder D.N.G., Ghose N., Ghose A., Lahiri S. Systemic manifestations in chronic arsenic toxicity in absence of skin lesions in West Bengal, Indian. J. Med. Res. 2009, 129:75-82.
29. Martin G.R., Wallace J.L. Gastrointestinal inflammation: a central component of mucosal defence and repair. Exp. Biol. Med. 2006, 231:130-137.
30. Mazzucchelli L., Hauser C., Zgraggen K., Wagner H., Hess M., Laissue J.A., Mueller C. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am. J. Pathol. 1994, 144:997-1007.
31. Mukherjee S., Das D., Mukherjee M., Das A.S., Mitra C. Synergistic effect of folic acid and vitamin B12 in ameliorating arsenic-induced oxidative damage in pancreatic tissue of rat. J. Nutr. Biochem. 2006, 17:319-327.
32. Mullin J.M., Laughlin K.V., Marano C.W., Russo L.M., Soler A.P. Modulation of tumor necrosis factor-induced increase in renal (LLC-PK1) transepithelial permeability. Am. J. Physiol. 1992, 263:F915-F924.
33. Nanthakumar N.N., Fusunyan R.D., Sanderson I., Walker W.A. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. PNAS 2000, 97:6043-6048.
34. Navas-Acien A., Silbergeld E.K., Pastor-Barriuso R., Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 2008, 300:814-822.
35. Parvez F., Wasserman G.A., Factor-Litvak P., Liu X.H., Slavkovich V., Siddique A.B., Sultana R., Sultana R., Islam T., Levy D., Mey J.L., van Geen A., Khan K., Kline J., Ahsan H., Graziano J.H. Arsenic exposure and motor function among children in Bangladesh. Environ. Health Perspect. 2011, 119:1665-1670.
36. Sakurai T., Kaise T., Matsubara C. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms. Chem. Res. Toxicol. 1998, 11:273-283.
37. She L., Turner J.R. Role of epithelial cells in initiation and propagation of intestinal inflammation. Eliminating the static: tight junction dynamics exposed. Am. J. Physiol. Gastrointest. Liver 2006, 290:G577-G582.
38. Singh N., Kumar D., Lal K., Raisuddin S., Sahu A.P. Adverse health effects due to arsenic exposure: modification by dietary supplementation of jaggery in mice. Toxicol. Appl. Pharmacol. 2010, 242:247-255.
39. Snow E.T., Sykora P., Durham T.R., Klein C.B. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?. Toxicol. Appl. Pharmacol. 2005, 107:S557-S564.
40. Sonnier D.I., Bailey S.R., Schuster R.M., Lentsch A.B., Pritts T.A. TNF-α induces vectorial secretion of IL8 in Caco-2 cells. J. Gastrointest. Surg. 2010, 14:1592-1599.
41. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 2000, 74:289-299.
42. Suenaert P., Bulteel V., Lemmens L., Noman M., Geypens B., Van Assche G., Geboes K., Ceuppens J.L., Rutgeerts P. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am. J. Gastroenterol. 2002, 97:2000-2004.
43. Van de Walle J., Hendrickx A., Romier B., Larondelle Y., Schneider Y.J. Inflammatory parameters in Caco-2 cells: effect of stimuli nature, concentration, combination and cell differentiation. Toxicol. in Vitro 2010, 24:1441-1449.
44. Van de Wiele T., Gallaway C., Creed J., Kubachka K., Basta N., Dayton E., Whitacre S., Du Laing G., Bradham K. Arsenic metabolism by human gut microbiota upon in vitro digestion of contaminated soils. Environ. Health Perspect. 2010, 118:1004-1009.
45. Vega L., Styblo M., Patterson R., Cullen W., Wang C., Germolec D. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 2001, 172:225-232.
46. Wang L., Scabilloni J.F., Antonini J.M., Rojanasakul Y., Castranova V., Mercer R.R. Induction of secondary apoptosis, inflammation, and lung fibrosis after intratracheal instillation of apoptotic cells in rats. AJP - Lung Physiol. 2006, 290:L695-L702.
47. Wang T.C., Jan K.Y., Wang A.S.S., Gurr J.R. Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells. Mutat. Res. 2007, 615:75-86.
48. Wang X., Li Y., Yang X. Astragalus polysaccharide reduces inflammatory response by decreasing permeability of LPS-infected Caco2 cells. Int. J. Biol. Macromol. 2013, 61:347-352.
49. Wasserman G.A., Liu X.H., Parvez F., Ahsan H., Factor-Litvak P., van Geen A., Lavkovich V., Lolacono N.J., Cheng Z., Hussain I., Momotaj H., Graziano J.H. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ. Health Perspect. 2004, 112:1329-1333.
50. Wu M.M., Chiou H.Y., Ho I.C., Chen C.J., Lee T.C. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environ. Health Perspect. 2003, 111:1429-1438.
51. Yang S.K., Eckmann L., Kagnoff M.F. Colon epithelial-cell lines express multiple chemokines. Gastroenterology 1995, 108:A946.